These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33590875)

  • 41. Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma.
    Zhou X; Tan FK; Guo X; Arnett FC
    Arthritis Rheum; 2006 Aug; 54(8):2626-31. PubMed ID: 16871529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.
    Serratì S; Chillà A; Laurenzana A; Margheri F; Giannoni E; Magnelli L; Chiarugi P; Dotor J; Feijoo E; Bazzichi L; Bombardieri S; Kahaleh B; Fibbi G; Del Rosso M
    Arthritis Rheum; 2013 Jan; 65(1):258-69. PubMed ID: 22972461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Human Skin Model Recapitulates Systemic Sclerosis Dermal Fibrosis and Identifies COL22A1 as a TGFβ Early Response Gene that Mediates Fibroblast to Myofibroblast Transition.
    Watanabe T; Baker Frost DA; Mlakar L; Heywood J; da Silveira WA; Hardiman G; Feghali-Bostwick C
    Genes (Basel); 2019 Jan; 10(2):. PubMed ID: 30678304
    [No Abstract]   [Full Text] [Related]  

  • 44. Xenopus laevis il11ra.L is an experimentally proven interleukin-11 receptor component that is required for tadpole tail regeneration.
    Suzuki S; Sasaki K; Fukazawa T; Kubo T
    Sci Rep; 2022 Feb; 12(1):1903. PubMed ID: 35115663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
    Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
    Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PGC-1α regulates autophagy to promote fibroblast activation and tissue fibrosis.
    Zhang Y; Shen L; Zhu H; Dreissigacker K; Distler D; Zhou X; Györfi AH; Bergmann C; Meng X; Dees C; Trinh-Minh T; Ludolph I; Horch R; Ramming A; Schett G; Distler JHW
    Ann Rheum Dis; 2020 Sep; 79(9):1227-1233. PubMed ID: 32482644
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
    Mori Y; Chen SJ; Varga J
    Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting of NADPH oxidase in vitro and in vivo suppresses fibroblast activation and experimental skin fibrosis.
    Dosoki H; Stegemann A; Taha M; Schnittler H; Luger TA; Schröder K; Distler JH; Kerkhoff C; Böhm M
    Exp Dermatol; 2017 Jan; 26(1):73-81. PubMed ID: 27576129
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Suppressive Regulation by MFG-E8 of Latent Transforming Growth Factor β-Induced Fibrosis via Binding to αv Integrin: Significance in the Pathogenesis of Fibrosis in Systemic Sclerosis.
    Fujiwara C; Uehara A; Sekiguchi A; Uchiyama A; Yamazaki S; Ogino S; Yokoyama Y; Torii R; Hosoi M; Suto C; Tsunekawa K; Murakami M; Ishikawa O; Motegi SI
    Arthritis Rheumatol; 2019 Feb; 71(2):302-314. PubMed ID: 30175895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synergistic activation of extracellular signal-regulated kinase in human dermal fibroblasts by human telomerase reverse transcriptase and transforming growth factor-beta1.
    Liu WR; Lu L; Rosenberg DS; Procaccini PS; Mustoe TA
    J Surg Res; 2007 Dec; 143(2):415-21. PubMed ID: 17662305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis.
    Dees C; Tomcik M; Zerr P; Akhmetshina A; Horn A; Palumbo K; Beyer C; Zwerina J; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2011 Jul; 70(7):1304-10. PubMed ID: 21450749
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 5-HT
    Chaturvedi S; Misra DP; Prasad N; Rastogi K; Singh H; Rai MK; Agarwal V
    Int J Rheum Dis; 2018 Dec; 21(12):2128-2138. PubMed ID: 30207074
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Composition of TWIST1 dimers regulates fibroblast activation and tissue fibrosis.
    Palumbo-Zerr K; Soare A; Zerr P; Liebl A; Mancuso R; Tomcik M; Sumova B; Dees C; Chen CW; Wohlfahrt T; Mallano T; Distler A; Ramming A; Gelse K; Mihai C; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2017 Jan; 76(1):244-251. PubMed ID: 27113414
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytokine-mediated induction of human xylosyltransferase-I in systemic sclerosis skin fibroblasts.
    Ly TD; Kleine A; Plümers R; Fischer B; Schmidt V; Hendig D; Distler JHW; Kuhn J; Knabbe C; Faust I
    Biochem Biophys Res Commun; 2021 Apr; 549():34-39. PubMed ID: 33662666
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TGF-β-mediated upregulation of brachyury contributes to constitutively up-regulated type I collagen expression in skin fibroblasts: possible role in systemic sclerosis.
    Teng L; Yao G; Gao R; Wang Y; Lin W; Jin Y; Wang Y; Chen H; Wang Z; Chen J
    Eur J Dermatol; 2019 Aug; 29(4):359-365. PubMed ID: 31625918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosis.
    Wu M; Pedroza M; Lafyatis R; George AT; Mayes MD; Assassi S; Tan FK; Brenner MB; Agarwal SK
    Arthritis Rheumatol; 2014 Apr; 66(4):1010-21. PubMed ID: 24757152
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts.
    Brembilla NC; Montanari E; Truchetet ME; Raschi E; Meroni P; Chizzolini C
    Arthritis Res Ther; 2013 Oct; 15(5):R151. PubMed ID: 24289089
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
    Raschi E; Chighizola CB; Cesana L; Privitera D; Ingegnoli F; Mastaglio C; Meroni PL; Borghi MO
    Arthritis Res Ther; 2018 Aug; 20(1):187. PubMed ID: 30157947
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis.
    Noda S; Asano Y; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
    PLoS One; 2012; 7(2):e32272. PubMed ID: 22384200
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis.
    Castelino FV; Bain G; Pace VA; Black KE; George L; Probst CK; Goulet L; Lafyatis R; Tager AM
    Arthritis Rheumatol; 2016 Dec; 68(12):2964-2974. PubMed ID: 27390295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.